- Pro Power Save Reviews Canada: Is It the Ultimate Energy Saver?
- A Summer Reboot for Your Gut Health and Achy Joints | By Dr Marty Jaramillo, Medical Advisor to AposHealth
- The Relevance of Income Protection Insurance to the Medical Industry
- LICORbio Expands Portfolio with Strategic Acquisition of SERVA Electrophoresis
- Field Medical Closes Oversubscribed $35 Million Series B to Advance Development of FieldForce™ Pulsed Field Ablation Platform
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.
Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.
Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.
"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"
Kontakt.io Launches Temperature Monitoring Solution for Critical Healthcare Supplies
Cloud-based solution monitors temperature and humidity of refrigerators and regulated rooms with real-time alerts to ensure the safety and effectiveness of medications and biologicals
Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms
Partnership further validates Ethris’ novel technology platform based on stabilized non-immunogenic mRNA, which overcomes the innate instability and immunity of mRNA.
InspireMD Announces CE Mark Approval for CGuard ® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
CGuard® Prime was developed incorporating extensive user feedback and optimizes deliverability and deployment of the proven CGuard stent.
Nectero Medical Secures Category III CPT Codes for Investigational Therapy to Treat Small- to Medium-Sized AAAs
This designation represents a key milestone toward future reimbursement and broader clinical adoption.
Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future
Backed by $2 Million, Droplet IV is Set to Launch its Revolutionary Automatic IV-Line Flushing Device in EU & US in 2026
Droplet IV today announced the successful completion of a $2 million funding round to enable launch of its first automatic IV-line flushing device in the
Materna Medical Announces Ellora™ and Additional Close on $20M Series B2
The round welcomed new funds GLIN Impact Capital, Wealthing VC Club, and Citrine Angels, and was led by InnovaHealth Partners and other key existing investors.
Industry Expert Byline
A Summer Reboot for Your Gut Health and Achy Joints | By Dr Marty Jaramillo, Medical Advisor to AposHealth
You may be surprised to learn the role that your gut health plays in the health of your joints. Remember, your gut is the home to thousands of microorganisms that play a role in your digestion, immunity, and overall health. When your gut microbiome is unbalanced, it can cause inflammation throughout your body, including in your joints, which is why eating healthy is vital for anyone living with chronic joint pain.
Breakthrough in Patient-Derived Stem Cells for Therapeutic Regenerative Medicine
These studies shed light on the scientific controversy of whether activation of the Wnt/β-catenin pathway induces human stem cell pluripotency or differentiation.
Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation
“MERCURIUS™ Total DRUG-seq represents a new frontier in transcriptome-scale compound screening,” said Riccardo Dainese, CEO and Co-founder of Alithea Genomics. “We are empowering scientists to capture the full complexity of transcriptional responses—at a massive scale and with minimal cost. This product opens the door to discovering new biology, new targets, and new drugs faster than ever before.”
Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies
Sun Nuclear Acquires Oncospace, AI-Focused Radiation Oncology Software Provider
This strategic move underscores the Sun Nuclear commitment to leverage cutting-edge technology to improve treatment outcomes on behalf of their customers.
Boston Scientific Reveals Agreement to Acquire SoniVie Ltd.
“Renal denervation for hypertension is an exciting medical advancement for the millions of patients it may help and is supported by positive results from contemporary clinical trials and ongoing research,” said Lance Bates, senior vice president and president, Interventional Cardiology Therapies, Boston Scientific. “We believe the addition of the differentiated, ultrasound-based TIVUS system can complement our expansive interventional portfolio with a minimally invasive therapy for patients with hypertension and provides opportunity for future advancements in this space.”
FDA Medical Device Updates
Riliprubart Earns Orphan Drug Designation in the US for Antibody-mediated Rejection in Solid Organ Transplantation
This designation reflects Sanofi’s commitment to addressing a critical unmet need in transplant medicine, where AMR remains a significant challenge with no FDA-approved treatments available.
Our Experts - Byline Articles
Non-Profit Organization News and Updates
Medical Imaging Technologies and Their Impact on Modern Healthcare
Healing Headlines, Transforming Lives: Hospitals in the News
CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
“Among the safe, minimally invasive colorectal cancer screening options, CT colonography is more effective at preventing and detecting cancer—and is also more cost-effective—than stool DNA testing,” Dr. Pickhardt said. “Furthermore, CT colonography can provide for extracolonic screening for things like osteoporosis and cardiovascular disease.”
Carotid Plaque May Pose Danger Over Time
Data from the Rotterdam Study in the Netherlands.
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System
Latest Swoop® System software delivers a substantial leap in image quality for AI-powered portable MR brain imaging.
S.L. Raheja Hospital, Mumbai Completes 50 TAVI Procedures, Showcasing Excellence Minimally Invasive Heart Solutions
This milestone puts S.L. Raheja Hospital, Mahim, at the forefront of cardiac care in Mumbai, with one of Mumbai’s most advanced Structural Heart Programs.
Delray Medical Center Acquires Intuitive da Vinci 5 Surgical System
Da Vinci 5 is the newest entry to the da Vinci portfolio of systems, which also includes da Vinci X®, da Vinci Xi®, and da Vinci SP®. The system can be used for minimally invasive surgical procedures for urology, gynecology, thoracic, and general surgeries.
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
SynerFuse® Announces Chief Technology Officer | Michael Park, M.D., Ph.D.
Dr. Park is a former principal investigator for the SynerFuse® proof-of-concept study and primary inventor of SynerFuse® technology.
Clinilabs Expands Executive Leadership Team With Key Appointments
Clinilabs, LLC, a leading full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and medical technology development, today announced the appointments of
Rad AI Names Demetri Giannikopoulos as Chief Growth Officer to Accelerate AI-Driven Radiology Healthcare Growth
Mr. Demetri brings over 20 years of experience in healthcare technology, with a track record of advancing AI adoption in complex clinical settings.
RapidRatings Appoints Charlie Minutella as CEO to Accelerate Strategic Growth and Innovation
Charlie Minutella brings a wealth of industry knowledge and a strong track record of leadership, innovation, and operational excellence. His appointment ushers in a new chapter for RapidRatings as it continues to shape the future of financial risk intelligence.
